Financial advisers to investors in the Chinese pharmaceutical industry. Beijing Elite Management Consulting was founded in 1997 and has an active client base of 1200 domestic pharmaceutical companies in China. Each year Elite Consulting conducts commercial due diligence for over USD 500 million of direct investment in the pharmaceutical industry. Elite Capital Advisers provides M&A brokerage, facilitation, and capital investment and is among the most active advisers in China. In 2010, Elite sourced and brokered the $210 million purchase of a major Chinese R&D pharmaceutical business by an MNC -- the first deal of its kind to successfully close. Elite also facilitated direct investment deals of more than $90 million by leading investors.